At 58 years of age, this female patient faced the daunting challenge of malignant tumor diagnosis in her left breast, setting the stage for a journey of resilience and hope. Commencing ECCT therapy on 5 November 2012, marked a crucial step in her battle against breast cancer.
在58岁时，这位女性患者面临了左乳腺恶性肿瘤的艰巨挑战，开启了一段充满韧性和希望的旅程。于2012年11月5日开始接受ECCT治疗，标志着她对抗乳腺癌的重要一步。Initially, the patient experienced troubling symptoms of itching and pain in the affected breast. However, with the implementation of ECCT as Breast Cancer Treatment, notable improvements were observed. The size of the tumor in the left breast exhibited a slight decrease, accompanied by the alleviation of pain and itching, offering a glimmer of hope amidst adversity.
最初，患者在受影响的乳房经历了令人不安的瘙痒和疼痛症状。然而，随着ECCT的实施，观察到了明显的改善。左乳腺肿瘤的大小略有减小，伴随着疼痛和瘙痒的减轻，为困境中的一丝希望。Despite undergoing surgery in September 2013, which left behind a residual tumor mass, the patient remained steadfast in her commitment to ECCT therapy. This ongoing treatment regimen proved instrumental in the gradual elimination of the remaining tumor mass, as evidenced by the shrinking scar from the surgical intervention.
尽管在2013年9月接受了手术，手术留下了残留的肿瘤块，但患者仍然坚定地致力于ECCT治疗。这种持续的治疗方案在逐渐消除残留的肿瘤块方面起到了关键作用，手术干预留下的疤痕在缩小。Moreover, the therapeutic benefits of ECCT extended beyond tumor reduction, with the scar tissue gradually diminishing in size. The body's natural mechanisms absorbed and eliminated the remaining tumor, paving the way for a remarkable transformation in the patient's health.
此外，ECCT的治疗效益不仅仅局限于肿瘤减少，疤痕组织也在逐渐缩小。身体的自然机制吸收并清除了残留的肿瘤，为患者的健康带来了显著的改善。
Comentarios